Showing results (271-280 of 623) with videos related to
Sort By:
Pageof 63
Urologie (Heidelberg, Germany)|April 13, 2026
[Update of S3 guideline on metastatic prostate cancer-guideline recommendations and expert consensus]Marc-Oliver Grimm, Christian Gratzke, Boris Hadaschik, et al.Scientific Reports|September 2, 2021
Silicon-photomultiplier-based PET/CT reduces the minimum detectable activity of iodine-124David Kersting, Walter Jentzen, Pedro Fragoso Costa, et al.EJNMMI Physics|February 15, 2021
Comparing lesion detection efficacy and image quality across different PET system generations to optimize the iodine-124 PET protocol for recurrent thyroid cancerDavid Kersting, Walter Jentzen, Miriam Sraieb, et al.Journal of Medical Imaging and Radiation Oncology|July 25, 2020
Is there a connection between immunohistochemical markers and grading of lung cancer with apparent diffusion coefficient (ADC) and standardised uptake values (SUV) of hybrid 18F-FDG-PET/MRI?Ole Martin, Nils-Martin Bruckmann, Julian Kirchner, et al.Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|October 1, 2023
Quantification performance of silicon photomultiplier-based PET for small 18F-, 68Ga- and 124I-avid lesions in the context of radionuclide therapy planningDavid Kersting, Alexandros Moraitis, Miriam Sraieb, et al.Lung Cancer (Amsterdam, Netherlands)|December 7, 2019
Clinical response to crizotinib and emergence of resistance in lung adenocarcinoma harboring a MET c-Cbl binding site mutationMarcel Wiesweg, Thomas Herold, Martin Metzenmacher, et al.European Journal of Nuclear Medicine and Molecular Imaging|March 21, 2025
Prognostic value of [18F]FDG- and PSMA-PET in patients evaluated for [177Lu]Lu-PSMA therapy of mCRPCTugce Telli, Leonor Lopes, Madeleine Karpinski, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 21, 2023
Oncologic Staging with 68Ga-FAPI PET/CT Demonstrates a Lower Rate of Nonspecific Lymph Node Findings Than 18F-FDG PET/CTTristan T Demmert, Kelsey L Pomykala, Helena Lanzafame, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2019
PET/MRI Versus PET/CT for Whole-Body Staging: Results from a Single-Center Observational Study on 1,003 Sequential ExaminationsOle Martin, Benedikt M Schaarschmidt, Julian Kirchner, et al.European Journal of Nuclear Medicine and Molecular Imaging|July 9, 2015
iROLL: does 3-D radioguided occult lesion localization improve surgical management in early-stage breast cancer?Christina Bluemel, Andreas Cramer, Christoph Grossmann, et al.Pageof 63